Sandy Draper
Stock Analyst at Guggenheim
(2.92)
# 1,459
Out of 5,113 analysts
113
Total ratings
59.14%
Success rate
20.63%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $560.21 | -22.89% | 12 | Jul 24, 2024 | |
| EVH Evolent Health | Maintains: Hold | $34 → $28 | $3.97 | +605.29% | 10 | May 14, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $222.52 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $193.85 | - | 15 | Feb 15, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $2.74 | +264.96% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $43.49 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $3.49 | -42.69% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $178.70 | +47.17% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.70 | +4,193.07% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $95.50 | -1.57% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.14 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $23.94 | +113.03% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $224.74 | -42.60% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $42.04 | +30.83% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $101.38 | +65.71% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $34.77 | -65.49% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $7.93 | +530.91% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $11.68 | +456.51% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $2.37 | +1,418.99% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $218.10 | -23.43% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.45 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $10.05 | +526.87% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $560.21
Upside: -22.89%
Evolent Health
May 14, 2024
Maintains: Hold
Price Target: $34 → $28
Current: $3.97
Upside: +605.29%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $222.52
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $193.85
Upside: -
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.74
Upside: +264.96%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $43.49
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $3.49
Upside: -42.69%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $178.70
Upside: +47.17%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.70
Upside: +4,193.07%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $95.50
Upside: -1.57%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $7.14
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $23.94
Upside: +113.03%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $224.74
Upside: -42.60%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $42.04
Upside: +30.83%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $101.38
Upside: +65.71%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $34.77
Upside: -65.49%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $7.93
Upside: +530.91%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $11.68
Upside: +456.51%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $2.37
Upside: +1,418.99%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $218.10
Upside: -23.43%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.45
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $10.05
Upside: +526.87%